Nothing Special   »   [go: up one dir, main page]

HK1257271A1 - 單環內酰胺抗生素的鹽和固體形式 - Google Patents

單環內酰胺抗生素的鹽和固體形式

Info

Publication number
HK1257271A1
HK1257271A1 HK18116415.3A HK18116415A HK1257271A1 HK 1257271 A1 HK1257271 A1 HK 1257271A1 HK 18116415 A HK18116415 A HK 18116415A HK 1257271 A1 HK1257271 A1 HK 1257271A1
Authority
HK
Hong Kong
Prior art keywords
amino
oxo
peaks
compound
methyl
Prior art date
Application number
HK18116415.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1257271B (zh
Inventor
Eric Aubin
Andreas Fisch
Michael Mutz
Bernd Ulrich Riebesehl
Marc SCHOENHENTZ
Anthony Casarez
Zaixing LI
Mika Lindvall
Heinz Ernst Moser
Folkert Reck
Vijay SETHURAMAN
Robert Lowell Simmons
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1257271A1 publication Critical patent/HK1257271A1/zh
Publication of HK1257271B publication Critical patent/HK1257271B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK18116415.3A 2015-09-23 2016-09-20 單環內酰胺抗生素的鹽和固體形式 HK1257271B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562222430P 2015-09-23 2015-09-23
US62/222,430 2015-09-23
PCT/CN2016/099482 WO2017050218A1 (en) 2015-09-23 2016-09-20 Salts and solid forms of monobactam antibiotic

Publications (2)

Publication Number Publication Date
HK1257271A1 true HK1257271A1 (zh) 2019-10-18
HK1257271B HK1257271B (zh) 2021-02-05

Family

ID=

Also Published As

Publication number Publication date
IL258254B (en) 2021-02-28
US20180273522A1 (en) 2018-09-27
RU2018114480A3 (zh) 2020-06-09
LT3353175T (lt) 2020-10-12
CL2019003324A1 (es) 2020-04-17
JP2018528241A (ja) 2018-09-27
ES2817537T3 (es) 2021-04-07
CA2999794C (en) 2023-08-15
EP3353175A1 (en) 2018-08-01
EP3353175B1 (en) 2020-08-12
MA42946A (fr) 2018-08-01
WO2017050218A1 (en) 2017-03-30
US10919887B2 (en) 2021-02-16
MA42946B1 (fr) 2020-10-28
SMT202000480T1 (it) 2020-11-10
HUE050849T2 (hu) 2021-01-28
KR20180054816A (ko) 2018-05-24
EP3353175A4 (en) 2019-06-26
RU2754180C2 (ru) 2021-08-30
MX377532B (es) 2025-03-10
CN108137573B (zh) 2021-06-11
PL3353175T3 (pl) 2021-02-22
RS60805B1 (sr) 2020-10-30
AU2016327264B2 (en) 2019-06-27
RU2018114480A (ru) 2019-10-23
HRP20201423T1 (hr) 2020-12-11
BR112018005805A2 (pt) 2018-10-16
EA037569B1 (ru) 2021-04-15
CL2018000745A1 (es) 2018-06-22
AU2016327264A1 (en) 2018-05-10
PT3353175T (pt) 2020-09-10
PH12018500653B1 (en) 2022-05-04
CA2999794A1 (en) 2017-03-30
IL258254A (en) 2018-05-31
PH12018500653A1 (en) 2018-10-01
CY1123509T1 (el) 2022-03-24
KR102749337B1 (ko) 2025-01-03
SI3353175T1 (sl) 2020-11-30
EA202092620A1 (ru) 2021-06-30
MX2018003592A (es) 2018-06-18
EA201890771A1 (ru) 2018-09-28
DK3353175T3 (da) 2020-09-14
JP6837480B2 (ja) 2021-03-03
CN108137573A (zh) 2018-06-08

Similar Documents

Publication Publication Date Title
EP3353175B1 (en) Salts and solid forms of a monobactam antibiotic
US9309285B2 (en) Macrocyclic broad spectrum antibiotics
TWI601746B (zh) 線型肽抗生素
CN108137574B (zh) 羟烷基噻二唑衍生物
BR112014003146B1 (pt) 3,4-dihidro-1h-[1,8]naftiridinonas substituídas com homopiperidinila antibacterianas, composição farmacêutica compreendendo os referidos composto e processos para preparação destes
EP3719020B1 (en) Crystal form of beta-lactamase inhibitor and preparation method therefor
CN102838625B (zh) 四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
HK1257271B (zh) 單環內酰胺抗生素的鹽和固體形式
BR112018005805B1 (pt) Sais e formas sólidas de um antibiótico monobactama
US20190309017A1 (en) Glutaminase inhibitors
JPH06192292A (ja) 新規ポリペプチド化合物及びその塩
CN118475569A (zh) 四氢异喹啉类化合物的可药用盐、晶型及其用途
TW200829242A (en) Penem prodrugs
HK40022902A (zh) 一種β-內酰胺酶抑制劑的晶型及其製備方法
HK1252275B (zh) 羥烷基噻二唑衍生物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240915